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Abstract
Background: Various factors including cardio-metabolic disorders are found to be correlated with frailty. With the
increase in age, older adults are likely to have elevated blood glucose level. In this study we intend to investigate
the prevalence and incidence of frailty in the pre-diabetic and diabetic community dwelling elderly population and
the associated risk factors.
Methods: At baseline total of 10,039 subjects with a mean age of 70.51 (±7.82) were included. A total of 6,293 older
adults were followed up at 12 months. A Frailty index (FI) with 32 items was developed using Rockwood’s cumulative
deficits method. Frailty index ≥0.25 was used as cut-off criteria for the diagnosis of frailty. Diagnosis of pre-diabetes and
diabetes was set according to the World Health Organization (WHO) criteria for fasting plasma glucose (FPG) level.
Chi-square tests were performed to compare percentages by 3 major groups (non-diabetes, pre-diabetes, diabetes),
ANOVA and student’s t-tests was used to compare means of group for continuous variables. Multiple logistic regression
models were performed to estimate the risk factors for frailty in non-diabetic, pre-diabetic and diabetic elderly
populations using baseline and longitudinal data.
Results: Diabetic population had a much higher prevalence (19.32%) and incidence (12.32%) of frailty, compared to that
of non-diabetic older adults (prevalence of 11.92% and incidence of 7.04%). And pre-diabetics had somewhat similar
prevalence of 11.43% and slightly higher incidence of 8.73% for frailty than non-diabetic older adults. Diabetics were at 1.
36 (95% CI = 1.18,1.56) and 1.56 (95%CI = 1.32,1.85) fold increase in risk of frailty compared to non-diabetic population for
prevalence and incidence, respectively. Being female, urban living, high waist circumference, less house work and need
regular anti-diabetic medications were independent risk factors only in pre-diabetic and diabetic older adults.
Conclusion: This study confirms that diabetes is an independent serious chronic condition to increase the risk of frailty in
community dwelling older adults in northern China. To effectively delay or avoid frailty, older adults should be advised for
taking proper control of blood glucose level and avoiding the associated risk factors and implementing the protective
factors in primary-care setting.
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Background
Ageing is associated with multisystem functional decline,
which could lead to future frailty [1, 2]. Various factors
including cardio-metabolic disorders are found to be
correlated with frailty, among which diabetes in the eld-
erly population cannot be excluded. With the increase in
age, older adults are likely to have alteration in glucose
metabolism which may be due to decrease in insulin
sensitivity and resistance, islet cell dysfunction or re-
duced beta-cell sensitivity leading to elevated glucose
level [3]. Diabetes now a very common chronic disease
in the elderly population, itself affects all major organs,
therefore affecting multisystem function, which in turn
could aid in facilitating acceleration of frailty [4, 5]. Im-
paired fasting glucose (IFG) or pre-diabetes is a transi-
tional state of diabetes which could also be an associated
risk factor for frailty. Previous studies have shown that
older diabetic adults are at higher risk of being frail [6–
8], however, these study did not examine the risks for
frailty in other elevated blood glucose older population.
Frailty is a geriatric condition which is known to be re-
versed or at least delayed, if suitable interventions are
implemented on time [9–11]. Moreover, for such inter-
ventions to be implemented, the at-risk population and
the risk factors should be identified. In this study, we in-
tend to investigate the prevalence and incidence of
frailty in community dwelling subjects more than
55 years old with elevated blood glucose (pre-diabetes,
diabetes), and if these population shared the common
risk factors as normal blood glucose frail population.
Methods
Study population
This study is a secondary analyses based on Beijing Lon-
gitudinal study of ageing II (BLSA II) [12]. The baseline
study was started from July till November 2009 and a
follow-up study was performed after a year from August
2010 to January 2011. A multi-stage cluster random
sampling method was performed to select aged 55 and
older representative community cohort of Beijing resi-
dents. Three urban districts and one rural county were
selected for this study.
Data collection
A well designed structured questionnaire was prepared
based upon the updated international and domestic
guidelines which included socio-economic demographic
questionnaires, comprehensive geriatric assessments
(CGA) including self-reported history of chronic diseases
and performance based functional assessments, history
of medications (daily medications within 2 weeks of
interview) and existing pre-clinical conditions. A face to
face interview was performed by trained clinicians based
upon the questionnaire and vital signs, fasting blood
glucose, lipids levels, uric acid and hematological test
samples were also collected during the same time. The
participants were followed and evaluated after 12 months
by the same questionnaire. Data inconsistency and miss-
ing values were queried and resolved for both visits.
Measures
We used Rockwood’s accumulation of deficits method
[13, 14] to calculate frailty in the BLSA-II study. The
frailty index (FI) consisting of 32 items was developed,
based upon the methodology introduced by Searle and
colleagues [15]. FI ≥ 0.25 was used as the cut-off criteria
for frailty [14]. FI items include: 1) 11 chronic condi-
tions, for which the participants were asked “Have you
ever been diagnosed for the following conditions by a
doctor?” Chronic conditions included hypertension, car-
diovascular disease, chronic obstructive pulmonary dis-
ease (COPD), stroke, dementia, arthritis, tumor, cataract,
deafness, heart failure and renal failure; 2) Four func-
tional assessment scales: a) Mini-Nutrition assessment
(MNA), where cutoff was set < 24 as poor nutrition sta-
tus and ≥ 24 as good nutritional status, b) Tinetti’s
performance-oriented assessment of mobility (POMA),
where cutoff was set < 24 as poor mobility status and 24
as good mobility status, c) Geriatric Depression Scale-15
items (GDS-15), where cutoff was set < 8 as depressed
status and ≥ 8 as normal status, d) Mini-Mental State
Examination (MMSE), where cutoff was set < 24 as cog-
nitively impaired state and 24 or more as normal cogni-
tive function; 3) Six disease screening questionnaires
(joint pain and inflammation, gout, risk of fall, osteopor-
osis, arterial sclerosis and Parkinson's disease); 4) Eight
age-related symptoms questionnaires (less activity, fa-
tigue, weight loss, urinary inconsistence, fecal inconsis-
tence, memory loss, vision and hearing loss) were
included and all participants were screened for these
geriatric symptoms. 5) Body mass index (BMI) was cal-
culated by weight/height*height, where BMI <19 was
considered to be underweight and 2 blood test results
were included for: a) Dyslipidemia: Triglyceride (TG)
≥200 mg/dl or Total Cholesterol (TCH) ≥ 240 mg/dl or
low-density lipoprotein cholesterol (LDL) ≥ 160 mg/dl or
high-density lipoprotein cholesterol (HDL) < 40 mg/dl).
b) Serum uric acid (UA): UA > 420 IU for male, UA >
360 IU for female. Examination of blood sample was
done using an automatic biochemical analysis device
(Sysmex Chemix-180, Sysmex Infosystems, Kobe,Japan).
All included items had less than 5% missing values, and
continuous measures were dichotomized into frailty
markers (1 = presence,0 = absence) based on the refer-
enced cutoffs for Chinese population [12].
Diagnosis of diabetes and pre-diabetes was set accord-
ing to the World Health Organization (WHO) criteria of
fasting plasma glucose (FPG) and self-history of the
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patient. Diabetes was defined by WHO criteria of fasting
plasma glucose (FPG) greater than or equal to
7.0 mmol/l (126 mg/dl). Impaired fasting glucose (IFG)
level of 6.1 to 6.9 mmol/l (110 mg/dl to 125 mg/dl) were
taken as “pre-diabetic/pre-diabetes” subjects. Self-history
of diagnosed diabetes by doctors at the tertiary hospitals
and taking anti-diabetic medications were also consid-
ered to be the “diabetic/diabetes” population All other
population apart from diabetes and pre-diabetes were
taken as “non-diabetic” population. The FPG test was
determined using “OneTouch Ultra, Life-Scan, Inc., Mil-
pitas, CA” device during the interview session along with
two other blood analyses.
Statistical analyses
Chi-square tests were performed to compare percent-
ages by three major groups (non-diabetes, pre-diabetes
and diabetes), ANOVA and student’s t-tests were used
to compare means of the groups for continuous vari-
ables. The prevalence and incidence of frailty with 95%
confidence interval (CI) were calculated using baseline
and follow-up data, and rates of frailty in different
demographic and clinical subgroups were estimated.
Subgroup analysis was based on demographic conditions
(urban or rural residence, gender, age group (55–
64years, 65–74years,75–84years, ≥85 years) and clinical
conditions including number of co-existing comorbidity
(include 11 chronic conditions in the FI) divided into 3
sub-categories (no comorbidity, 1–2, ≥3), polypharmacy
(0–3 types/day, ≥4 types/day), anti-diabetic medication
(never taken, occasionally, regularly), BMI status (<19,
19–28, ≥28), hours of outdoor activity per day
(none,<0.5 hr, 0.5-1 hr,2-3 hrs,≥4 hrs), doing or helping
with house work (never, occasionally, regularly). To esti-
mate the association between blood glucose levels with
prevalence and incidence of frailty, we calculated un-
adjusted and adjusted odds ratios (ORs) at baseline and
risk ratios (RRs) at one-year follow-up of pre-diabetes
and diabetes using single and multiple logistic models
adjusted for age, sex, residency and comorbidity.
We then performed stratified analysis to compare as-
sociated factors of prevalence and incidence of frailty be-
tween elevated blood glucose (pre-diabetes and diabetes)
subgroup and normal blood glucose (non-diabetes) sub-
group. Backward elimination variable selection method
was used and variables initially entered in both models
were those included in subgroup analysis and other pos-
sible factors like current marital status, low education
(less than middle school education was considered low
education level), history of smoking and drinking, ir-
regular lifestyle, and high waist circumference (cut-off
for Chinese adults male ≥ 85 cm, female ≥ 80 cm) [16].
Estimating the relative risk in cohort studies was based
on Deddens 2004 and Zou 2004 [17, 18]. All tests were
2-tailed and P < .05 was considered statistically signifi-
cant. Multiple comparisons were adjusted using Bonfer-
roni's criteria. All analyses were performed using SAS
version 9.3 (SAS Institute, Inc., Cary, NC,U.S.A).
Results
Baseline characteristics
Participant’s characteristics at baseline and 12-months
follow-up visits are shown in Additional file 1: Table S1
in the Appendix. The mean age of participants at base-
line was 70.51 years (SD 7.82) and the majority were
women (61.3%), living in urban area (78.4%) and had
middle school or higher education (61.45%). Of those,
25.73% participants had no chronic disease, and 20.77%
had 3 or more chronic diseases and 22.34% were taking
more than four prescription drugs. Considering living
habits, only 4.78% had no regular outdoor exercise and
12.35% subjects never performed any household works.
Prevalence of frailty
At baseline, population without diabetes was 6410, 875
were pre-diabetics and 2634 were diabetics, of which a
total of 1373 were frail (Table 1). The highest prevalence
of frailty was found in the population with diabetes
(19.32%), whereas prevalence of frailty in pre-diabetics
(11.43%) and non-diabetes (11.92%) population was
quiet similar. The prevalence of frailty was found to be
higher in female compared to male in all 3 groups ie
non-diabetes, pre-diabetes and diabetes (13.16%, 13.71%,
21.05% vs 9.97%, 8.12%, 16.39%) respectively, urban
population were distinctively frail compared to rural
(14.51%, 14.70%, 22.25% vs 2.93%, 3.52%, 5.62%) in the 3
groups. The prevalence of frailty was found to increase
with age and was highest in oldest of old age group ≥85
(28.83%, 47.62%, 42.31%). Prevalence of frailty increased
with the number of co-morbidity in all 3 groups; highest
in subjects with 3 or more co-morbidity (43.56%,
45.90%, 49.34%). Similarly, prevalence increased with
polypharmacy, subjects with 4 or more medications per
day had higher prevalence of frailty (33.24%, 36.67%,
36.19%) in the 3 groups, respectively.
Incidence of frailty
A total of 7,314 older adults were followed up at 12 months,
of which 6,293 were eligible subjects (Table 1). At one year
follow-up, 527 new cases of frailty were detected, and the
overall incidence of frailty increased from non-diabetes to
pre-diabetes and diabetes group (7.04, 8.73, 12.32%, p <
0.001). Such increasing trends were also found in other
demographic and clinical subpopulations. For instance, the
incidence in females were increased by glucose status (7.87,
8.84, 14.10%) compared to those in the males (5.82, 8.57,
9.65%) in non-diabetic, pre-diabetic and diabetic subjects
respectively. For age group between 55 to 64, the incidence
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of frailty was the lowest compared with other age groups,
but the incidence in pre-diabetic and diabetic subjects were
both significantly higher than subjects with normal glucose,
2.76% vs. 4.44% vs. 4.62%, respectively. For subgroups aged
65–74 and 75–84 years, the incidence also increased from
6.36% to 9.24 and 11.22% and from 12.17% to 13.14 and
20.33%, respectively. For the oldest age group, there was
not enough data in pre-diabetic subjects to show the in-
creasing trend, but the incidence rate in diabetic subjects
was much higher than non-diabetes (42.11% vs. 25.32%).
Table 1 Prevalence and incidence of frailty by blood glucose status
















Diabetes (n = 1575)
N (%)
P value
Overall 764 (11.92) 100 (11.43) 509 (19.32) <.0001 283 (7.04) 50 (8.73) 194 (12.32) <.0001
Residence
Urban 722 (14.51) 91 (14.70) 483 (22.2) <.0001 247 (7.76) 45 (10.71) 184 (14.10) <.0001
Rural 42 (2.93) 9 (3.52) 26 (5.62) 0.0254 36 (4.31) 5 (3.27) 10 (3.70) 0.7925
Gender
Male 249 (9.97) 29 (8.12) 160 (16.39) <.0001 95 (5.82) 21 (8.57) 61 (9.65) 0.0038
Female 515 (13.16) 71 (13.71) 349 (21.05) <.0001 188 (7.87) 29 (8.84) 133 (14.10) <.0001
Age group
55–64 70 (3.84) 8 (3.00) 51 (8.12) <.0001 33 (2.76) 8 (4.44) 19 (4.62) 0.1370
65–74 285 (10.51) 41 (11.17) 2013 (17.67) <.0001 114 (6.36) 23 (9.24) 81 (11.22) 0.0002
75–84 362 (21.17) 41 (18.64) 234 (28.85) <.0001 116 (12.17) 18 (13.14) 86 (20.33) 0.0003
≥85 47 (28.83) 10 (47.62) 22 (42.31) 0.0712 20 (25.32) 1 (14.29) 8 (42.11) 0.2433
Coexisting co-morbidity
0 16 (0.78) 1 (0.39) 11 (1.99) 0.0237 42 (3.09) 7 (4.09) 29 (7.55) 0.0005
1–2 356 (10.27) 43 (8.65) 200 (13.55) 0.0007 174 (7.69) 31 (8.88) 95 (9.88) 0.1164
≥3 392 (43.56) 56 (45.90) 298 (49.34) 0.0877 67 (16.92) 12 (22.64) 70 (30.57) 0.0004
Polypharmacy/day
0–3 409 (7.70) 45 (6.25) 149 (9.19) 0.0353 206 (5.97) 41 (8.47) 116 (10.84) <.0001
≥4 354 (33.24) 55 (36.67) 359 (36.19) 0.3299 75 (13.69) 9 (10.59) 74 (15.04) 0.5210
Anti-diabetic medication
Never / / 68 (10.86) / / 36 (8.82) 0.1794
Occasionally / / 11 (22.00) / / 5 (15.63)
Regularly / / 430 (21.96) / / 153 (13.48)
BMI status
<19 58 (22.75) 4 (23.53) 19 (30.65) 0.4275 12 (9.30) 0 1 (2.94) 0.3112
19–28 547 (10.61) 64 (9.61) 373 (18.18) <.0001 224 (6.85) 34 (7.71) 148 (11.94) <.0001
≥28 154 (15.88) 32 (17.11) 114 (22.53) 0.0065 47 (7.83) 16 (13.33) 43 (14.68) 0.0040
Hours of outdoor activity/day
0 93 (32.18) 13 (28.26) 57 (43.18) 0.0545 7 (5.74) 4 (15.38) 4/49 (8.16) 0.2389
<0.5 h 171 (15.21) 26 (16.05) 127 (26.19) <.0001 51 (7.10) 16 (14.16) 44 (15.88) <.0001
0.5–1 h 353 (12.32) 46 (13.03) 227 (18.49) <.0001 146 (7.71) 20 (8.62) 93 (12.13) 0.0014
2–3 h 125 (8.09) 13 (5.99) 83 (13.65) <.0001 58 (6.24) 10 (7.04) 43 (11.75) 0.0036
≥4 h 22 (3.88) 2 (2.13) 15 (8.47) 0.0189 21 (6.12) 0 (0) 10 (8.93) 0.0680
Doing or helping with house work
Never 160 (22.22) 23 (20.18) 116 (29.90) 0.0096 33 (9.02) 6 (10.53) 31 (15.82) 0.0517
Occasionally 252 (11.09) 41 (12.89) 173 (18.21) <.0001 111 (7.61) 22 (10.38) 73 (12.56) 0.0017
Regularly 352 (10.30) 36 (8.13) 220 (16.98) <.0001 139 (6.34) 22 (7.24) 90 (11.28) <.0001
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Crude and adjusted risks of frailty comparing pre-diabetic
and diabetic subjects with those with normal blood glu-
cose at baseline and follow-up survey
Using both unadjusted and adjusted logistic regression, we
found having diabetes increased the risk of prevalence
frailty at baseline (Additional file 2: Table S2 Appendix 2),
the crude and adjusted OR were 1.77 (95%CI = 1.56–2.00,
P < .0001), and 1.36 (95%CI = 1.18–1.56, P < .0001), control-
ling for age, sex, residency and co-morbidity. However, the
prevalence of frailty in pre-diabetics was not statistically
higher than those in non-diabetics (unadj. OR = 0.95, adj.
OR = 0.96). For longitudinal risk of frailty at one-year
follow-up visit, subjects with diabetes were statistically
higher than those with normal blood glucose using both
unadjusted RR (1.75, 95%CI = 1.47–2.08, p < 0.001) and ad-
justed RR by age, sex, residency and comorbidity (adj. RR =
1.56, 95%CI = 1.32–1.85, p < .0001). Pre-diabetics also
showed an increased risk of frailty, the unadjusted RR and
adjusted RR were 1.24 (95%CI = 0.93–1.65, p = 0.1439) and
1.28 (95%CI = 0.96–1.70, p = 0.0886) respectively, however
didn't reach the statistical significant level.
Associated factors for risk of prevalence of frailty in
elevated blood glucose (pre-diabetic and diabetic)
population and normal blood glucose (non-diabetic)
population
In Table 2, we stratified the baseline participants by blood
glucose level status, ie. elevated blood glucose (pre-dia-
betes and diabetes) and normal blood glucose (non-dia-
betic) and developed multiple logistic model of frailty for
each stratum. Both strata shared four common risk factors
and three protective factors for frailty, including urban liv-
ing (adj. ORs = 2.29 and 3.07 in elevated and normal glu-
cose group, respectively), less than 6-h sleep per day (adj.
ORs = 1.56 and 1.48), with comorbidity (adj. ORs = 6.33
and 11.82 for having 1–2 diseases; 43.56 and 60.46 for
having 3 or more diseases), polypharmacy (adj. ORs = 3.44
and 2.50), and being married (adj. ORs = 0.60 and 0.66,
more hours of outdoor activity (adj. ORs = 0.24 to 0.20
and 0.23 to 0.19) and helping with house work regularly
(adj. ORs = 0.56 and 0.43). Three more risk factors were
found in pre-diabetic and diabetic subgroup, such as low
education (adj. OR = 1.60), irregular life style (adj. OR =
4.74), not often drinking milk (adj. OR = 1.61). Being fe-
male and older age statistically increased the prevalence of
frailty only in non-diabetes subpopulation.
Associated factors for risk of incidence of frailty in
elevated blood glucose (pre-diabetic and diabetic)
population and normal blood glucose (non-diabetic)
population
In Table 3, we investigated the risk factors of incidence
of frailty longitudinally by blood glucose status subpopu-
lation using separate multiple logistic models. The
common risk factors for frailty incidence in both popula-
tions were age (adj. RR = 1.70, 2.62, 4.88 and 2.01, 3.49,
7.72 in elevated and normal glucose groups, respect-
ively), and comorbidity (adj. RR = 1.19 and 2.13 for 1–2
diseases, 3.02 and 3.43 for 3 or more diseases, respect-
ively); and the common protective factor was receiving
regular medical consultation (adj. RR = 0.79 and 0.72 in
elevated and normal glucose groups, respectively). Two
risk factors including urban-living (adj. RR = 2.28),
higher waist circumference (adj. RR = 1.37) and two pro-
tective factors including being male (adj. RR =
0.67),doing house work regularly (adj. RR = 0.67) were
only among pre-diabetes and diabetes subjects. For
the non-diabetic participants polypharmacy was a risk
factor of frailty (adj. RR = 1.44) and awareness of their
blood glucose status was protective against frailty
(adj. RR = 0.72).
Discussion
Our results for the overall prevalence and incidence of
frailty in the population without diabetes and with dia-
betes are consistent with previous studies [6–8, 12, 19–
23]. Both rates were found to be the most lowest in
older population without diabetes, slightly higher in pre-
diabetic and highest in diabetic population. Such in-
creasing trends of frailty by blood glucose level were
similarly found in age and other demographic sub-
groups, showing diabetes is an independent predictor of
the prevalence and incidence of frailty. Whereas, pre-
diabetes or impaired fasting glucose although not very
distinct could be playing an intermediary role along with
other risk factors in the acceleration of frailty. Therefore,
attention should be given to the elderly population with
impaired fasting glucose levels as well. Older adults with
more co-morbidity and taking more medications were
found to have a very high prevalence and incidence of
frailty in all three groups (ie non-diabetics, pre-diabetics
and diabetics), indicating that frailty is severely affected
by multi co-morbidity and polypharmacy, which is in
consistent with previous studies [6–8, 19–23], and if
were additionally to be affected with pre-diabetes or dia-
betes, the condition could worsen [24, 25]. More import-
antly, elderly population with pre-diabetes are known to
have low grade systemic inflammation and oxidative stress
[25], leading to metabolic dysfunction which may affect
the components of physical frailty, therefore should not be
ignored. Therefore, physicians should advise older adults
to follow proper blood sugar control techniques at an
early phase of abnormal blood glucose status.
Elevated blood glucose populations shared some com-
mon risk factors as non-diabetic populations in both
cross-sectional and longitudinal analysis. At baseline, the
following subgroups demonstrated higher prevalence of
frailty despite of blood glucose status: not being married,
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urban residency, daily sleep less than 6 h, co-morbidity,
polypharmacy, less outdoor activity time and rarely helping
with house work. To screen more people with frailty in
community, elderly subjects with above characteristics
should be targeted. However, lower education and irregular
life style and less intake of milk were only correlated with
the prevalence of frailty in pre-diabetic and diabetic sub-
jects. In contrast, advanced age and being female were posi-
tively associated with frailty only among subjects with
normal blood glucose. In light of this, health care providers
should consider screening for frailty of at-risk older people
and followed by targeted interventions for deficit or risk is-
sues. The different sets of risk factors for normal and ele-
vated blood glucose subgroups have been identified using
longitudinal data. Among pre-diabetic and diabetic older
subjects, the unmodifiable risk factors were female sex,
urban living, and modifiable risk factors were higher waist-
circumference, less house work and in need of taking regu-
lar anti-diabetic medication. Among older adults with nor-
mal blood glucose, only poly-pharmacy and unawareness of
blood glucose were found to be independent risk factor of
developing frailty. Therefore, the interventions in commu-
nity health centers among non-diabetic subjects should tar-
get on consultation on polypharmacy prescription and
improving individual's awareness of blood glucose level.
Considering the serious and worse adverse events among
frail older people with diabetes, screening and intervention
of frailty should be proactively implemented as soon as pre-
diabetes is detected.
Consistent with previous studies, doing regular house-
hold work and performing more outdoor activity had
positive effect for frail older adults [26–28]. Therefore,
Table 2 Backward elimination variable selection method to investigate if the elevated blood glucose (pre-diabetes and diabetes)
frail population shared common risk factors as other frail population at baseline
Prevalence of frailty in pre-diabetic and diabetic
subjects (n = 3509)
Prevalence of frailty in subjects with normal blood glucose
(n = 6530)
Adj. OR (95%CI) P value Adj. OR (95%CI) P value
Male vs female / / / 0.66 (0.50,0.87) 0.0031
Currently married vs not 0.60 (0.43,0.85) 0.0041 0.66 (0.50,0.88) 0.0052
Urban vs rural 2.29 (1.30,4.05) 0.0022 3.07 (1.85,5.09) <.0001
Age group
55–64 / / / Ref Ref Ref
65–74 / / / 1.60 (1.09,2.37) 0.0649
75–84 / / / 2.33 (1.56,3.49) 0.1907
≥85 / / / 4.25 (2.04,8.83) 0.0026
Low education vs higher 1.60 (1.18,2.15) 0.0022 / / /
Not regular lifestyle vs regular 4.74 (2.02,11.14) 0.0004 / / /
Not Regularly drinking milk vs regular 1.61 (1.19,2.18) 0.0020 / / /
Less than 6 h/day sleep vs more sleep 1.56 (1.11,2.20) 0.0100 1.48 (1.12,1.96) 0.0053
Number of comorbiditya
0 Ref Ref Ref Ref Ref Ref
1–2 6.33 (2.70,14.80) 0.8612 11.82 (5.49, 25.42) 0.0489
≥3 43.56 (18.40,103.16) <.0001 60.46 (27.72, 131.88) <.0001
Polypharmacy
≥4 types/day
3.44 (2.57,4.62) <.0001 2.50 (1.93,3.22) <.0001
Hours of outdoor activity daily
None Ref Ref Ref Ref Ref Ref
0.5–1 h 0.31 (0.17,0.54) 0.3381 0.26 (0.17, 0.41) 0.0660
2–3 h 0.24 (0.12,0.45) 0.0247 0.229 (0.14, 0.38) 0.0129
≥4 h 0.20 (0.08,0.50) 0.0559 0.190 (0.09,0.40) 0.0291
Doing or helping with house work
Never Ref Ref Ref Ref Ref Ref
Occasionally 0.80 (0.52,1.24) 0.6714 0.66 (0.44, 0.97) 0.9925
Regularly 0.56 (0.37,0.85) 0.0029 0.43 (0.29, 0.63) <.0001
aNumber of comorbidity include any of the 11 chronic conditions in the FI
Chhetri et al. BMC Geriatrics  (2017) 17:47 Page 6 of 8
routinely proper physical activities, participation in
more house work and losing waist for those with
higher waist circumference should be an urgent need
to prevent frailty in elderly subjects [29–31]. Our
study has also demonstrated some more protective
factors of frailty, such as drinking milk, maintaining
regular daily life-style and awareness blood glucose
level and getting routinely geriatric health consult-
ation. Geriatricians and physicians should take in ac-
count of these factors while advising the older
patients.
Our study is the first to show the relationship of elevated
blood glucose status with frailty in Chinese older adults.
However, some limitations of this study are worth mention-
ing: we used fasting plasma glucose, personal history of
diagnosis of diabetes and use of anti-diabetic medication as
the diagnosis criteria for pre-diabetes and diabetes, oral glu-
cose tolerance testing was not taken (as it is in-practicable
for such a large cohort) and glycosylated hemoglobin
(HbA1c) levels were not measured which might have mis-
classified some of the participants. Future studies in the
subject could focus in the limitation of this study. And
more studies are warranted on dose–response relationship
and their etiology rationale between blood glucose level
and frailty, as well as cost-effectiveness analyses on man-
aging frailty among pre-diabetes and diabetes in various
community settings.
Conclusion
This study confirms that diabetes is an independent
serious chronic condition in older adults to increase
the risk of frailty. Highest prevalence and incidence
of frailty is observed in elderly population with dia-
betes. Frailty in elevated blood glucose older adults
shares common risk factors, as other non-diabetic
frail older population. Being female, urban living,
high waist circumference, less house work and need
regular anti-diabetic medications are independent
risk factors only in pre-diabetic and diabetic older
adults. Geriatricians should advise the older patients
both with elevated and normal blood glucose levels
by different strategies individually. Additionally, re-
sults of this study could facilitate future studies in
identification of the at-risk community dwelling
older subjects and implementation of suitable inter-
ventions for frailty.
Table 3 Backward elimination variable selection method to investigate if the elevated blood glucose (pre-diabetes and diabetes)
frail population shared common risk factors as other frail population at one-year follow-up
Incidence of frailty in pre-diabetes
and diabetes subjects (n = 2176)
Incidence of frailty in subjects with
normal blood glucose (n = 4117)
Adj. RR (95%CI) P value* Adj. RR (95%CI) P value*
Male vs female 0.67 (0.52,0.86) 0.0017 / /
Urban vs rural 2.28 (1.32, 3.91) 0.0030 / /
Age group
55–64 Ref Ref Ref Ref
65–74 1.70 (1.12, 2.58) 0.0125 2.01 (1.37,2.93) 0.0003
75–84 2.62 (1.71, 4.03) <.0001 3.49 (2.38,5.12) <.0001
≥85 4.88 (2.53, 9.42) <.0001 7.72 (4.61,12.94) <.0001
Regularly receiving medical consultation after baseline vs not receiving 0.79 (0.62,1.00) 0.0463 0.72 (0.58, 0.90) 0.0041
Regular anti diabetic treatment vs irregular 1.16 (0.91, 1.48) 0.2240 / /
Number of comorbiditya
0 Ref Ref Ref Ref
1–2 1.19 (0.83,1.70) 0.3386 2.13 (1.53, 2.98) <.0001
≥3 3.02 (2.07,4.39) <.0001 3.43 (2.30, 5.12) <.0001
Polypharmacy
≥4 types/day
/ / 1.44 (1.11, 1.86) 0.0062
Doing or helping with house work
Never Ref Ref / /
Occasionally 0.87 (0.61,1.24) 0.4344 / /
Regularly 0.67 (0.47,0.95) 0.0247 / /
Waist circumference high vs normal 1.37 (0.99,1.89) 0.0549 / /
Self-awareness of blood glucose level / / 0.72 (0.57, 0.90) 0.0036
*Number of comorbidity include any of the 11 chronic conditions in the FI
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